Forge Biologics | Manufacturing Gene Therapies for Life
About

Mission

Our foundation is hope

Manufacturing gene therapies for life.

Our mission is to enable access to life changing gene therapies and help bring them from idea into reality. We partner with innovators in the gene therapy community: scientists, physicians, biotech and pharma companies and patient groups. We bring expertise in gene therapy manufacturing and therapeutics development to the table, helping champion teams that are navigating the long road from the lab bench to the bedside. With a patients-first approach, we are forging new models for working together to better accelerate these transformative medicines to reach those who need them the most.

About

Approach

Our foundation is hope

Forge is building capacity to directly address the growing demand for gene therapy manufacturing. 

Forge is currently building the "Hearth”, a 200,000+ ft2 custom-designed cGMP facility, dedicated to AAV viral vector manufacturing. We offer end-to-end manufacturing services to accelerate gene therapy programs from preclinical stage through clinical, and on to commercial manufacturing.

With the Hearth as our foundation, Forge is building a promising pipeline of disease-modifying AAV-based therapies to potentially help patients with rare genetic diseases. Forge is a true gene therapy development engine bringing together access to quality, in-house manufacturing, the experience of our team in gene therapy product development, and an exciting pipeline of new therapies for patients.

About

Leadership

Our foundation is hope
Timothy J. Miller, Ph.D.

CEO, President and Co-Founder

Our foundation is hope
Timothy J. Miller, Ph.D.

CEO, President and Co-Founder

Our foundation is hope
David Dismuke, Ph.D.

Chief Technical Officer

Our foundation is hope
Erandi De Silva, Ph.D.

Co-Founder & Senior Vice President of Product Development

Our foundation is hope
Jaysson Eicholtz

Co-Founder & Chief Operating Officer

Our foundation is hope
John Maslowski

Chief Commercial Officer

Our foundation is hope
Maria Escolar, M.D.

Chief Medical Officer

Our foundation is hope
Christopher Shilling

Senior Vice President of Regulatory Affairs and Quality

Our foundation is hope
Magdalena Tyrpien

Senior Vice President and Head of Business Development

Our foundation is hope
Steven Goden

Senior Vice President of Finance & Operations

Our foundation is hope
Christina Perry

Senior Vice President of Finance & Investor Relations

Our foundation is hope
Juan Ruiz, M.D., Ph.D.

Senior Vice President of Clinical Affairs

Our foundation is hope
Frank Agbogbo, Ph.D.

Vice President of Process Development

Our foundation is hope
Meghan Leonard

Vice President of Quality Management

Our foundation is hope
About

Board

Our foundation is hope
Timothy J. Miller

Forge Biologics

Chris Garabedian

Xontogeny

Matthew Hammond

RA Capital

Fred Callori

Xontogeny

Molly Bonakdarpour

Drive Capital

About

Scientific & Manufacturing Advisory Board 

Our foundation is hope
Steven J. Gray, Ph.D.

UT Southwestern

Robert Kotin, Ph.D.

Stealth Newco

Karen Kozarsky, Ph.D.

SwanBio Therapeutics

Haiyan Ma, Ph.D.

Northern Biomolecular Services

Simon Waddington, Ph.D.

University College London

5/5 (1 Review)